cjc-1295 ipamorelin growth hormone secretagogue clinical study is one of the several non-FDA approved releasing peptides that is commonly used in longevity and wellness clinics. This peptide differs from the others primarily due to long serum GHRH & GHRPs: Key Differences

J Drug Deliv Sci Technol 72:103362

SymWhite 377 Helps reduce the appearance of dark spots and discoloration

Mild Side Effects These side effects are reported anecdotally and tend to resolve on their own within a few days of use or dose adjustment: Headache or light-headedness Mild nausea or upset stomach (especially with oral use) Fatigue or lethargy in the first few days of use Appetite changes (increase or decrease) Injection site irritation redness, swelling, or tenderness Mild dizziness, nausea, and local irritation are among the most commonly reported side effects of subcutaneous BPC-157 injection, typically resolving within 2472 hours. Milekic, T

Loss of appetite

Lycopene supplementation of maternal and weanling high-fat diets influences adipose tissue development and metabolic outcomes of Sprague-Dawley offspring